MIS416 / Amplia Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MIS416 / Amplia Therap
NCT02228213: Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Completed
2b
93
RoW
MIS416, Saline, Placebo
Innate Immunotherapeutics, Syneos Health
Secondary Progressive Multiple Sclerosis
05/17
06/17

Download Options